UNSPSC 51392225: Medetomidine hydrochloride

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BH210P244U, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, monohydrochloride, (+-)- but more generally known as medetomidine hydrochloride, which bears US NIH Compound Identifier 68601. Most nations, for tariff and trade purposes, schedule medetomidine hydrochloride under HS 29332990 and SITC 51573.

As of Q4 2014, MEDETOMIDINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Medetomidine hydrochloride bears US NLM identifiers UMLS ID C0065852 and NCI Concept Code C81368. SMILES: CC1CCCC(C1C)C(C)C2C[NH]CN2.CL.

UNSPSC 51392225 Medetomidine hydrochloride (Commodity) encompasses pharmaceutical products procured by state and local health agencies, though recent posted opportunities show minimal direct activity under this specific code. The two most recent state and local postings tagged to this code involve naloxone procurement and a Texas Health and Human Services Commission request for information on direct-to-manufacturer prescription programs—neither of which involves medetomidine, an animal anesthetic and sedative agent. The nominal scope of the code (medetomidine hydrochloride) does not align with what these solicitations are actually buying, indicating either mis-tagging or sparse relevant activity under this specific commodity classification.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities and market intelligence on implementing a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program. No additional state or local opportunities involving medetomidine hydrochloride appear in recent postings. If pursuing this code, verify with issuing procurement offices whether medetomidine or related veterinary pharmaceuticals are included in their actual supply needs, as the recent activity record suggests limited current market demand at the state and local level for this specific commodity.